SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. H. Phillips, J. P. Westwood, V. Brocklebank, E. K. S. Wong, J. O. Tellez, K. J. Marchbank, S. McGuckin, D. P. Gale, J. Connolly, T. H. J. Goodship, D. Kavanagh, M. A. Scully, The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies, Journal of Thrombosis and Haemostasis, 2016, 14, 1
  2. 2
    Josep M. Campistol, Manuel Arias, Gema Ariceta, Miguel Blasco, Laura Espinosa, Mario Espinosa, Josep M. Grinyó, Manuel Macía, Santiago Mendizábal, Manuel Praga, Elena Román, Roser Torra, Francisco Valdés, Ramón Vilalta, Santiago Rodríguez de Córdoba, Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso, Nefrología, 2015, 35, 5, 421

    CrossRef

  3. 3
    Josep M. Campistol, Manuel Arias, Gema Ariceta, Miguel Blasco, Laura Espinosa, Mario Espinosa, Josep M. Grinyó, Manuel Macía, Santiago Mendizábal, Manuel Praga, Elena Román, Roser Torra, Francisco Valdés, Ramón Vilalta, Santiago Rodríguez de Córdoba, An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document, Nefrología (English Edition), 2015, 35, 5, 421

    CrossRef

  4. 4
    Carla M. Nester, Thomas Barbour, Santiago Rodriquez de Cordoba, Marie Agnes Dragon-Durey, Veronique Fremeaux-Bacchi, Tim H.J. Goodship, David Kavanagh, Marina Noris, Matthew Pickering, Pilar Sanchez-Corral, Christine Skerka, Peter Zipfel, Richard J.H. Smith, Atypical aHUS: State of the art, Molecular Immunology, 2015, 67, 1, 31

    CrossRef

  5. You have free access to this content5
    A. Mallett, P. Hughes, J. Szer, A. Tuckfield, C. Van Eps, S. B. Cambell, C. Hawley, J. Burke, J. Kausman, I. Hewitt, A. Parnham, S. Ford, N. Isbel, Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort, Internal Medicine Journal, 2015, 45, 10
  6. 6
    J. E. Sadler, Atypical HUS may become a diagnosis of inclusion, Blood, 2015, 125, 23, 3525

    CrossRef

  7. 7
    M. Kathryn Liszewski, John P. Atkinson, Complement regulator CD46: genetic variants and disease associations, Human Genomics, 2015, 9, 1

    CrossRef

  8. 8
    Divya Bhatia, Priyanka Khandelwal, Aditi Sinha, Pankaj Hari, Hae Il Cheong, Arvind Bagga, Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome, Pediatric Nephrology, 2015, 30, 12, 2215

    CrossRef

  9. 9
    D. Kavanagh, Y. Yu, E. C. Schramm, M. Triebwasser, E. K. Wagner, S. Raychaudhuri, M. J. Daly, J. P. Atkinson, J. M. Seddon, Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels, Human Molecular Genetics, 2015,

    CrossRef

  10. 10
    Miquel Blasco Pelicano, Santiago Rodríguez de Córdoba, Josep M. Campistol Plana, Síndrome hemolítico urémico atípico, Medicina Clínica, 2015, 145, 10, 438

    CrossRef

  11. 11
    C. John Sperati, Alison R. Moliterno, Thrombotic Microangiopathy, Hematology/Oncology Clinics of North America, 2015, 29, 3, 541

    CrossRef

  12. 12
    Bernard S. Kaplan, Rebecca L. Ruebner, Joann M. Spinale, Lawrence Copelovitch, Current treatment of atypical hemolytic uremic syndrome, Intractable & Rare Diseases Research, 2014, 3, 2, 34

    CrossRef

  13. 13
    M. Noris, M. Galbusera, S. Gastoldi, P. Macor, F. Banterla, E. Bresin, C. Tripodo, S. Bettoni, R. Donadelli, E. Valoti, F. Tedesco, A. Amore, R. Coppo, P. Ruggenenti, E. Gotti, G. Remuzzi, Dynamics of complement activation in aHUS and how to monitor eculizumab therapy, Blood, 2014, 124, 11, 1715

    CrossRef

  14. 14
    Caterina Mele, Giuseppe Remuzzi, Marina Noris, Hemolytic uremic syndrome, Seminars in Immunopathology, 2014, 36, 4, 399

    CrossRef

  15. 15
    K.-Y. Jen, Z.G. Laszik, Pathobiology of Human Disease, 2014,

    CrossRef

  16. 16
    David Kavanagh, Tim H. Goodship, Anna Richards, Atypical Hemolytic Uremic Syndrome, Seminars in Nephrology, 2013, 33, 6, 508

    CrossRef

  17. 17
    Edwin K.S. Wong, Tim H.J. Goodship, David Kavanagh, Complement therapy in atypical haemolytic uraemic syndrome (aHUS), Molecular Immunology, 2013, 56, 3, 199

    CrossRef

  18. 18
    Carla M. Nester, Multifaceted Hemolytic Uremic Syndrome in Pediatrics, Blood Purification, 2013, 35, 1-3, 86

    CrossRef

  19. 19
    C. Loirat, Síndrome hemolítico urémico infantil, EMC - Pediatría, 2013, 48, 1, 1

    CrossRef

  20. 20
    Fengxiao Bu, Nicolo Borsa, Ardissino Gianluigi, Richard J. H. Smith, Familial Atypical Hemolytic Uremic Syndrome: A Review of Its Genetic and Clinical Aspects, Clinical and Developmental Immunology, 2012, 2012, 1

    CrossRef

  21. 21
    Chantal Loirat, Jeffrey Saland, Martin Bitzan, Management of hemolytic uremic syndrome, La Presse Médicale, 2012, 41, 3, e115

    CrossRef

  22. 22
    Dana Provaznikova, Simon Rittich, Michal Malina, Tomas Seeman, Iuri Marinov, Magdalena Riedl, Ingrid Hrachovinova, Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP, Pediatric Nephrology, 2012, 27, 1, 73

    CrossRef

  23. 23
    C. Loirat, Syndrome hémolytique et urémique chez l’enfant, EMC - Pédiatrie - Maladies infectieuses, 2012, 7, 4, 1

    CrossRef

  24. 24
    T. Barbour, S. Johnson, S. Cohney, P. Hughes, Thrombotic microangiopathy and associated renal disorders, Nephrology Dialysis Transplantation, 2012, 27, 7, 2673

    CrossRef

  25. 25
    Maren Sullivan, Lisa A. Rybicki, Aurelia Winter, Michael M Hoffmann, Stefanie Reiermann, Hannah Linke, Klaus Arbeiter, Ludwig Patzer, Klemens Budde, Bernd Hoppe, Martin Zeier, Karl Lhotta, Andreas Bock, Thorsten Wiech, Ariana Gaspert, Thomas Fehr, Magdalena Woznowski, Gani Berisha, Angelica Malinoc, Oemer-Necmi Goek, Charis Eng, Hartmut PH Neumann, Age-Related Penetrance of Hereditary Atypical Hemolytic Uremic Syndrome, Annals of Human Genetics, 2011, 75, 6
  26. 26
    Chantal Loirat, Véronique Frémeaux-Bacchi, Atypical hemolytic uremic syndrome, Orphanet Journal of Rare Diseases, 2011, 6, 1, 60

    CrossRef

  27. 27
    K. Poolpol, B. Gadner, S. Neururer, A. Mellmann, H. Karch, D. Orth, R. Würzner, Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?, International Journal of Immunogenetics, 2011, 38, 5
  28. 28
    David Kavanagh, Timothy HJ Goodship, Atypical hemolytic uremic syndrome, Current Opinion in Hematology, 2010, 17, 5, 432

    CrossRef

  29. 29
    David Kavanagh, Tim Goodship, Genetics and complement in atypical HUS, Pediatric Nephrology, 2010, 25, 12, 2431

    CrossRef

  30. 30
    Zbigniew M. Szczepiorkowski, Jeffrey L. Winters, Nicholas Bandarenko, Haewon C. Kim, Michael L. Linenberger, Marisa B. Marques, Ravindra Sarode, Joseph Schwartz, Robert Weinstein, Beth H. Shaz, Guidelines on the use of therapeutic apheresis in clinical practice—Evidence-based approach from the apheresis applications committee of the American Society for Apheresis, Journal of Clinical Apheresis, 2010, 25, 3
  31. 31
    ALLISON M LESHER, WEN-CHAO SONG, Review: Complement and its regulatory proteins in kidney diseases, Nephrology, 2010, 15, 7